• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sanidad sacar? 456 f?rmacos de la financiaci?n p?blica (El Pais, June 27 2012)

Giuseppe

Emeritus
[Source: El Pais, full text: (LINK).]

Sanidad sacar? 456 f?rmacos de la financiaci?n p?blica



‎26 June ‎2012 | Mar?a R. Sahuquillo


El Ministerio de Sanidad propondr? ma?ana a las comunidades aut?nomas en el Consejo Interterritorial de Sanidad excluir de la financiaci?n p?blica 456 f?rmacos indicados para ?s?ntomas menores?. El listado de productos susceptibles de exclusi?n, que Sanidad ya ha enviado a los responsables auton?micos, incluye principios activos como la acetilcisteina, utilizada como mucol?tico ?y base de medicamentos como el Fluimucil?; el aciclovir, usado para combatir los herpes; la loperamida (que se comercializa como Fortasec, entre otros), indicado para atajar la diarrea; o tratamientos de la tos, como aquellos que contengan dextrometorfano ?t?pico en jarabes como el Bisolv?n?. El Gobierno calcula que la medida, prevista en el Real decreto de Medidas Urgentes del Sistema Nacional de Salud aprobado en abril, reportar? un ahorro de m?s de 440 millones de euros. Estos f?rmacos, ahora financiados por el Sistema Nacional de Salud, pasar?n a ser abonados totalmente por el paciente.

(?)
- ------
 
Back
Top Bottom